Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 7/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | CA1 | P00915 | 2/20 | 0.36 |
| ▸ | CA2 | P00918 | 2/20 | 0.36 |
| ▸ | CA7 | P43166 | 2/20 | 0.36 |
| ▸ | CA9 | Q16790 | 2/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | CA12 | O43570 | 1/20 | 0.35 |
| ▸ | CA3 | P07451 | 1/20 | 0.35 |
| ▸ | CA6 | P23280 | 1/20 | 0.35 |
| ▸ | CA5A | P35218 | 1/20 | 0.35 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 3/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.33 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1094237 | 1.00 | ACHE (0.47) | ACHETDP1GAAALDH1A1CA1 | |
| SCHEMBL254471 | 1.00 | ACHE (0.47) | ACHETDP1GAAALDH1A1CA1 | |
| SCHEMBL20661295 | 0.92 | ACHE (0.40) | ACHETDP1GAAALDH1A1CA1 | |
| SCHEMBL20661294 | 0.92 | ACHE (0.40) | ACHETDP1GAAALDH1A1CA1 | |
| SCHEMBL8779728 | 0.87 | — | — | |
| SCHEMBL17898104 | 0.86 | MLYCD (0.40) | ACHETDP1ALDH1A1TSHRLMNA | |
| SCHEMBL16841481 | 0.86 | TEAD4 (0.50) | ACHETDP1GAAALDH1A1TSHR | |
| SCHEMBL13772979 | 0.82 | CYP19A1 (0.48) | ACHETDP1ALDH1A1TSHRSMN1; SMN2 | |
| SCHEMBL28805138 | 0.79 | — | — | |
| SCHEMBL563967 | 0.79 | ACHE (0.50) | ACHETDP1GAAALDH1A1CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 672 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115837273-B | Modified metal nano catalyst and preparation method and application thereof | 厦门大学 | 2025-05-02 | — | — | CN | claimed |
| CN-115837273-A | Modified metal nano catalyst and preparation method and application thereof | 厦门大学 | 2023-03-24 | — | — | CN | claimed |
| CN-113851761-A | High reversible zinc-air battery | 中国科学院青岛生物能源与过程研究所 | 2021-12-28 | — | — | CN | claimed |
| CN-110477400-A | A kind of preparation method of the polypeptide compound of pheretima preparation | LANXI CHENMO BIOLOGICAL TECH CO LTD | 2019-11-22 | — | — | CN | claimed |
| CN-110477401-A | The purposes of sweet potato polypeptide compound | LANXI CHENMO BIOLOGICAL TECH CO LTD | 2019-11-22 | — | — | CN | claimed |
| CN-108522550-A | A kind of preparation method of sterilizing synergistic agent | 浦江县欧立生物技术有限公司 | 2018-09-14 | — | — | CN | claimed |
| CN-108034684-A | The preparation method of sweet potato polypeptide | 金华市铁骑士生物科技有限公司 | 2018-05-15 | — | — | CN | claimed |
| US-20110251289-A1 | NEW COMPOUNDS FOR THE TREATMENT OF CANCER | CSIR (ZA) | 2011-10-13 | — | — | US | claimed |
| EP-2321259-A2 | NEW COMPOUNDS FOR THE TREATMENT OF CANCER | CSIR (ZA) | 2011-05-18 | — | — | EP | claimed |
| WO-2009147632-A2 | NEW COMPOUNDS FOR THE TREATMENT OF CANCER | CSIR (ZA) | 2009-12-10 | — | — | WO | claimed |
| EP-2076493-A1 | PRODUCTION PROCESS FOR BICYCLIC TETRAHYDROPYRROLE COMPOUNDS | Laboratorios Del. Dr. Esteve, S.A. (ES) | 2009-07-08 | — | — | EP | claimed |
| WO-2007128457-A1 | PRODUCTION PROCESS FOR BICYCLIC TETRAHYDROPYRROLE COMPOUNDS | LABORATORIOS DEL DR. ESTEVE, S.A. (ES) | 2007-11-15 | — | — | WO | claimed |
| EP-1849770-A1 | Production process for bicyclic tetrahydropyrrole compounds | LABORATORIOS DEL DR. ESTEVE, S.A. (ES) | 2007-10-31 | — | — | EP | claimed |
| CN-1288222-C | Phosphorescent light-emitting material | LAIDE SCIENCE & TECHNOLOGY CO (CN) | 2006-12-06 | — | — | CN | claimed |
| US-6838019-B2 | Phosphorescent material and electroluminescent device using thereof | RITEK CORPORATION (TW) | 2005-01-04 | — | — | US | claimed |
| CN-1464027-A | Phosphorescent light-emitting material | LAIDE SCIENCE & TECHNOLOGY CO (CN) | 2003-12-31 | — | — | CN | claimed |
| EP-0580476-B1 | Process for producing 6E-leucotriene B4 and intermediates from this production process | OREAL (FR) | 1997-04-16 | — | — | EP | claimed |
| US-5292907-A | Process for the manufacture of (6E)-leukotriene B4 and intermediates of the said manufacturing process | L'OREAL (FR) | 1994-03-08 | — | — | US | claimed |
| EP-0580476-A1 | Process for producing 6E-leucotriene B4 and intermediates from this production process | L'OREAL (FR) | 1994-01-26 | — | — | EP | claimed |
| US-4120866-A | REACTING AN AROMATIC COMPOUND WITH A SULFOXIDE | BAYER AKTIENGESELLSCHAFT (DE) | 1978-10-17 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110251289-A1 | NEW COMPOUNDS FOR THE TREATMENT OF CANCER | DUT, BAD, TYMS | ACHE 4685/4885TDP1 965/4885GAA 1931/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.